Time: April 1, 2010 from 5:30pm to 7:30pm
Location: Ravinia Club
Street: Two Ravinia Drive, Suite 100
City/Town: Atlanta, GA 30346
Website or Map: http://www.raviniaclub.com
Phone: (770) 392-7300
Event Type: professional development series
Organized By: Ginny Mattox
Latest Activity: Mar 31, 2010
Topic: Online Communities, Brand Management Tips, and Productivity Tools
These tips and tools are mostly free of cost and ready to be used today. It just takes a little bit of learning and a knowledgeable guide like Cheyenne to get you started on your way to increased productivity, profit and more free time.... to avoid technology.
This talk is an extension of the Concourse Office Park Lunch and Learn presentation last week. Click through to get the notes to be ahead of the class on Thursday.
Please RSVP with firstname.lastname@example.org
The event will be on the bottom floor of the Ravinia Club
Cheyenne, a Computer Sciences graduate of Georgia Institute of Technology, has built and operates several online social networks in various niches for himself, user group communities and Fortune 500 companies. He is currently serving as President of the Atlanta ColdFusion User Group, where he has served on the board for 5 years.
Building and maintaining an evergrowing set of tools and tips utilizing the vast array of internet technologies at hand, he is constantly writing articles, teaching/presenting and consulting businesses, new and old, on particular strategies with emerging technologies that will maximize their company goals online.
Combining certified skills in psychology, programming and databases, Cheyenne utilizes search engine and social media optimization techniques combined with CPC, email and other strategies to achieve and measure these goals with constant analysis of web analytics.
Cheyenne is the Software Development Manager for Nucleus Holdings, an international group of companies whose key mission is to provide world-class innovative educational and marketing solutions for a diverse range of healthcare communication needs to the pharmaceutical industry and to academic scientific partners.